Homemade curd delays onset of diabetes, slowing down the progression of diabetes, lowering bad cholesterol and raising heart-protective good cholesterol. The findings have been reported in the latest issue of international journal Nutrition.
Read More »Diabetes In Control
Exercise Key in Control of Type 2 Diabetes: 103 Studies
The review found, studies that focused only on boosting exercise levels yielded greater benefits than those that tried to change patients’ diets, exercise habits and medication adherence all at once.
Read More »New Definition to Identify Children at Risk of Developing Metabolic Syndrome
The International Diabetes Federation (IDF) has developed a new definition of metabolic syndrome to help identify children at risk of developing the syndrome.
Read More »ADA: Lipid Effects of Diabetes Agents May Protect Arterial Function
Lipoprotein subfraction changes may be at the root of the dyslipidemia accompanying type 2 diabetes and help explain how thiazolidinediones improve carotid intima-media thickness.
Read More »Scientists Working On A New Insulin Pill
Insulin injections may soon be a thing of the past.
Read More »Anti-Fat Injection Can Melt Fat Away, Reducing Risk for Metabolic Syndrome
For those who eat to combat stress, researchers here may have made a dream come true — an injection that inhibits a well-know peptide, that makes fat melt away, at least in mice.
Read More »It’s Official – Stress Makes You Fat
Australian scientists have discovered why stress can make us fat. New research published in an international journal has revealed that chronic stress triggers the body’s fat cells to grow and multiply.
Read More »Beta-Blockers Exert Anti-Atherosclerotic Effects
Beta-blocker therapy can provide statistically significant regression of coronary artery plaque, and slow the progression to coronary atherosclerosis.
Read More »ADA: New Drug Alogliptin Controls Glucose Without Risk of Hypoglycemia
An investigational new agent, a highly selective dipeptidyl peptidase-IV (DPP-4) inhibitor, has shown good efficacy and safety in the treatment of type 2 diabetes mellitus, according to results of a phase 1 study.
Read More »ADA: Rosiglitazone Debated at ADA Meeting
They were waiting in a long line outside the hall to see Dr Steven Nissen (Cleveland Clinic, OH).
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.